CRBP icon

Corbus Pharmaceuticals

83 hedge funds and large institutions have $152M invested in Corbus Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less capital invested

Capital invested by funds: $166M → $152M (-$14M)

66% less call options, than puts

Call options by funds: $1.06M | Put options by funds: $3.15M

Holders
83
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.06M
Puts
$3.15M
Net Calls
Net Calls Change

Top Buyers

1 +$23.3M
2 +$3.13M
3 +$905K
4
IA
IFP Advisors
Florida
+$602K
5
Millennium Management
Millennium Management
New York
+$585K

Top Sellers

1 -$4.74M
2 -$2.27M
3 -$732K
4
Deutsche Bank
Deutsche Bank
Germany
-$524K
5
BlackRock
BlackRock
New York
-$469K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$119K
52
$110K
53
$102K
54
$99.1K
55
$88K
56
$88K
57
$86K
58
$75K
59
$74K
60
$64K
61
$57K
62
$52K
63
$48K
64
$37K
65
$26K
66
$23K
67
$13K
68
$8K
69
$7K
70
$6K
71
$6K
72
$4K
73
$4K
74
$2K
75
$2K